Company: INTS
Filing Date: 2025-08-12
Form Type: 8-K
Source: 0001567264-25-000081
Chunk: 1

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-08-12
Form: 8-K
Item: Item 5.03
Chunk 1
---
 30, 2025 stating that based on the Company’s balances in cash and cash equivalents as of June 30, 2025, plus the cash raised under the ATM in July 2025, the Company believes that it has at least $2,500,000 in stockholders’ equity, as required pursuant to the Stockholders’ Equity Requirement.

On August 8, 2025, the Company received a letter from Nasdaq stating that based on the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, the Staff has determined that the Company complies with the Stockholders’ Equity Requirement. The letter also stated that if at the time of its next periodic report the Company does not evidence compliance, it may be subject to delisting. At that time, the Staff will provide written notification to the Company, which may then appeal the Staff’s determination to a Hearings Panel.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                     
          3.1      Amendment to the Amended and Restated Bylaws, certified as of August 12, 2025.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL).             

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 12, 2025

  Intensity Therapeutics, Inc.                                                        
  By:                               /s/ Lewis H. Bender                               
                                    Name:                    Lewis H. Bender          
                                    Title:                   Chief Executive Officer  

[Signature Page to the Form 8-K]